Editorial: Pfizer's latest COVID breakthrough
Pfizer CEO Albert Bourla on Tuesday hailed his company's antiviral pill Paxlovid as a "game changer" after final trial data showed it reduced risk of hospitalization among high-ris…
Pfizer CEO Albert Bourla on Tuesday hailed his company's antiviral pill Paxlovid as a "game changer" after final trial data showed it reduced risk of hospitalization among high-ris…